Eli Lilly's $6B Alabama Plant: Trump's Drug Price Push

Eli Lilly plans to build a six billion dollar manufacturing plan in Huntsville, Alabama,

marking the largest investment in the state's history.

This major project stems from recent negotiations over prescription drug prices kicked off

by an executive order under President Trump.

The order aimed to tie United States drug prices to lower rates in other countries, sparking

talks that led to price concessions from companies and fresh commitments to invest here at home.

Eli Lilly's Huntsville facility stands out as a key win from those discussions.

Folks in Alabama are thrilled about the jobs and economic boost is brings to the rocket

city area.

Leaders credit Trump's direct negotiation style for finally tackling issues ignored for

years by past administrations.

But there's caution in the air too.

Turning that executive order into permanent law through Congress could mean government

price controls that hurt the growing biotech sector, including new plans like this one.

Instead, the pushes for free market changes to cut red tape, protect patents, and spark

more competition, which could lower costs long-term, while keeping America ahead in medical

innovation.

Alabama's leaders are watching closely to safeguard these gains.

That wraps Birmingham News today, brought to you with AI.

I'm Corey with The Story.